Overall survival data from LUX-Lung 7 head-to-head trial of afatinib ve
A reduction in the risk of death was observed in the LUX-Lung 7 trial for pa...
2016-10-11
文传商讯
Head-to-head study demonstrating Giotrif (afatinib) significantly impro
LUX-Lung 7 trial showed afatinib significantly reduced the risk of lung canc...
2016-04-14
文传商讯
European Committee for Medicinal Products for Human Use recommends appr
In LUX-Lung 8 trial, Giotrif® (afatinib) significantly improved overall ...
2016-03-03
文传商讯
